Identification and in vivo efficacy of small-molecule antagonists of integrin αvβ3 (the vitronectin receptor)

References

Page 1

	Year	Citations
Principles of Bone Biology Juliet Compston Clinical Endocrinology Bone BiologyBiomechanicsBone RemodelingOsteoarthritisSkeletal Biology	1997	1.4K
Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins. Martin Pfaff, Kirsten Tangemann, Beate Müller, Journal of Biological Chemistry Proteinlipid InteractionPeptide EngineeringMolecular BiologyPeptide ScienceInhibitory Activity	1994	533
Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist Chris Storgard, Dwayne G. Stupack, Alfred Jonczyk, Journal of Clinical Investigation	1999	309
A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. V. Wayne Engleman, G. Allen Nickols, F. Patrick Ross, Journal of Clinical Investigation SclerostinBone ResorptionOrthopaedic SurgeryOsteoclastic Bone DegradationMedicine	1997	287
Role of αvβ3 integrin in osteoclast migration and formation of the sealing zone Ichiro Nakamura, Mary F. Pilkington, Päivi T. Lakkakorpi, Journal of Cell Science	1999	197
Inhibition of neointimal hyperplasia by blocking αvβ3 integrin with a small peptide antagonist GpenGRGDSPCA* Eric T. Choi, Leslie Engel, Allan D. Callow, Journal of Vascular Surgery ImmunologyNeointimal HyperplasiaPathologyCell-matrix InteractionPeptide Therapeutic	1994	193
Selective αvβ3 integrin blockade potently limits neointimal hyperplasia and lumen stenosis following deep coronary arterial stent injury1: Sanjay S. Srivatsa, Lorraine A. Fitzpatrick, Peter W. Tsao, Cardiovascular Research	1997	162
The Integrin Ligand Echistatin Prevents Bone Loss in Ovariectomized Mice and Rats Michiko Yamamoto, John Fisher, Michael A. Gentile, Endocrinology MechanobiologySclerostinHealth SciencesBiochemistryBone Morphogenic Protein	1998	121
Discovery of Orally Active Nonpeptide Vitronectin Receptor Antagonists Based on a 2-Benzazepine Gly-Asp Mimetic William H. Miller, Doreen Alberts, Pradip K. Bhatnagar, Journal of Medicinal Chemistry PharmacotherapyExperimental PharmacologyPharmacodynamic ModelingTranslational PharmacologyPre-clinical Pharmacology	1999	116
Discovery of Potent Nonpeptide Vitronectin Receptor (α<sub>V</sub>β<sub>3</sub>) Antagonists Richard M. Keenan, William H. Miller, Chet Kwon, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryBiochemistryMedicineNatural Sciences	1997	114

Page 1